<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab10_7">
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Study period</th>
    <th>Incidence-rate ratio (IRR) (95% CI)</th>
    <th>
     <italic>p</italic>-value
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Baseline</td>
    <td>1.00</td>
    <td/>
   </tr>
   <tr>
    <td>During implementation</td>
    <td>0.76 (0.57–1.01)</td>
    <td>0.063</td>
   </tr>
   <tr>
    <td colspan="3">After implementation</td>
   </tr>
   <tr>
    <td>0–3 months</td>
    <td>0.62 (0.47–0.81)</td>
    <td>0.001</td>
   </tr>
   <tr>
    <td>7–9 months</td>
    <td>0.47 (0.34–0.65)</td>
    <td>&lt;0.001</td>
   </tr>
   <tr>
    <td>16–18 months</td>
    <td>0.34 (0.23–0.50)</td>
    <td>&lt;0.001</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <bold>Managerial Epidemiology Interpretation:</bold> A risk ratio less than 1.0 indicates that the outcome is less likely the study period than in the baseline period. The significant (a 
   <italic>p</italic>-value of less than 0.001) “protective (or reduction)” effect (IRR = 0.34) of intervention reducing catheter-related bloodstream infections persisted as long as 18 months after the introduction of the intervention (incidence rate ratio of 0.34, 95% CI: 0.23–0.50, 
   <italic>p</italic> &lt; 0.001).
  </p>
 </table-wrap-foot>
</table-wrap>
